Have you experienced internal bleeding from Pradaxa?

Pradaxa has been linked to severe side effects that lead to excessive internal bleeding and sometimes death.  If we find that the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc, did not properly test the safety and efficacy of Pradaxa, and you suffered at the hand of their negligence, you may be entitled to significant financial compensation. 

Do I have a case against Pradaxa?

We review our Pradaxa cases on an individual basis, so the best way to know if you have a case is to contact us directly and we will discuss the details of your situation.  As always, this consultation is completely free of charge and requires no obligation on your behalf.  We never make our clients part of a class action – we give our clients and their cases the individual attention it deserves. 

Do I need a Pradaxa Lawyer?

It is imperative that you contact a Pradaxa Lawyer to make sure you understand all options that are available to you.  We can help you decide the best course of action for your individual situation.  It is also important that you choose a law firm with a successful track record in pharmaceutical litigation.  The Pradaxa Lawyers at Cates Law Firm has an impeccable track record with these types of cases.  The level of commitment you will receive with our established, experienced, and successful law firm is unparalleled. 

What are the most common Pradaxa Side Effects?

Pradaxa (generically named dabigatran) is a blood thinner, designed to keep blood from clotting or coagulating in an effort to reduce the risk of stroke in patients who have specific heart rhythm disorders.  It is a common medication to treat patients with atrial fibrillation (AF).  It is important to note; however, that you or your loved one may have been prescribed Pradaxa for any number of related reasons. 

The most common serious side effects of Pradaxa include the following:

• Internal bleeding (gastrointestinal bleeding, brain hemorrhaging, etc)
• Death - hundreds of which have already been reported from patients who experienced internal bleeding while taking Pradaxa.

Facts about Pradaxa

• The manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc, recorded net sales of $12.6 billion Euros in 2010.
• More than 350,000 patients had been prescribed Pradaxa within the first 10 months of approval.
• At the end of 2010, the FDA released a safety announcement that it will begin evaluating these serious reports of excessive internal bleeding in patients of Pradaxa.

**Do not immediately stop taking Pradaxa without talking with your healthcare professional, as this can also carry the risk of stroke depending on your individual needs.